Melvin Silberklang

Statistics

Publications

Citations

1.5K

H-Index

Active since

1977

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Enzon Pharmaceuticals (United States)

Massachusetts Institute of Technology

University of California, San Francisco

Melvin Silberklang is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, molecular biology, and biochemistry.

Publications per year

1977–2007

Publications

[3] Use of in Vitro32P labeling in the sequence analysis of nonradioactive tRNAs

Melvin Silberklang, Amanda M. Gillum, Uttam L. RajBhandary · Methods in enzymology on CD-ROM/Methods in enzymology · 1979 · 440 citations

Life Sciences, Biochemistry, Molecular Biology +4

The use of nuclease P<sub>1</sub>in sequence analysis of end group labeled RNA

Melvin Silberklang, Amanda M. Gillum, Uttam L. RajBhandary · Nucleic Acids Research · 1977 · 240 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +9

Studies on the Sequence of the 3′‐Terminal Region of Turnip‐Yellow‐Mosaic‐Virus RNA

Melvin Silberklang, Alain Prochiantz, Anne‐Lise Haenni et al. · European Journal of Biochemistry · 1977 · 201 citations

Life Sciences, Microbiology, Molecular Biology +9

Skin Substitutes and Wound Healing: Current Status and Challenges

David E. Eisenbud, Sunny Luke, Melvin Silberklang · 2004 · 66 citations

Medicine, Plastic Surgery, Surgery +15

Characterization of a recombinant antibody produced in the course of a high yield fed‐batch process

David K. Robinson, Cheng-Han Chan, Chao‐Wu Yu et al. · Biotechnology and Bioengineering · 1994 · 65 citations

Pharmacy, Biochemistry, Biotechnology +17

1–5 of 21